Method for inhibiting the expression of Fas
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 1, 2000
Grant Date -
N/A
app pub date -
Feb 22, 1999
filing date -
Aug 23, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to a new method of treatment using compounds which are dual non-selective beta-adrenoceptor and alpha-1-adrenoceptor antagonists, in particularly the carbazolyl-(4)-oxypropanolainine compounds of Formula 1, as defined herein, for inhibiting the expression of Fas, a cell surface protein.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully